A clinical study to investigate safety, tolerability and dose of orally inhaled multiple doses of POL6014 in patients with Cystic Fibrosis A clinical study to investigate safety, tolerability and dose of orally inhaled multiple doses of PO ...
Phase-Ib/IIa study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of orally inhaled multiple doses of POL6014 in patients with Cystic Fibrosis Phase-Ib/IIa study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of ora ...
Glutamine supplementation for cystic fibrosis: a parallel group randomized controlled trial - Glutamine and CF Glutaminesupplementation for cystic fibrosis: a parallel group randomized controlled trial - Glutami ...
Glutamine supplementation for cystic fibrosis: a parallel group randomized controlled trial - Glutamine and CF Glutaminesupplementation for cystic fibrosis: a parallel group randomized controlled trial - Glutami ...
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...